FDA Consultant Specialist
FDA Consultant Specialist: This skill provides FDA regulatory consulting for medical device manufacturers.
Install
npx promptshop add fda-consultant-specialistDetails
What This Skill Does
- This skill provides FDA regulatory consulting for medical device manufacturers.
- It covers submission pathways, Quality System Regulation (QSR), HIPAA compliance, and device cybersecurity requirements.
- It is designed for regulatory affairs specialists and medical device manufacturers.
When to Use
- Determine FDA regulatory pathways.
- Prepare 510(k) submissions.
- Ensure QSR compliance.
- Address HIPAA requirements.
- Manage device cybersecurity.
- Plan pre-submission strategies.
Key Features
- FDA pathway selection decision framework.510(k) submission process workflow.
- QSR compliance guidance.
- HIPAA compliance for medical devices.
- Device cybersecurity best practices.
- Resources for FDA submissions.
FDA Consultant Specialist
FDA regulatory consulting for medical device manufacturers covering submission pathways, Quality System Regulation (QSR), HIPAA compliance, and device cybersecurity requirements.
Table of Contents
FDA Pathway Selection
510(k) Submission Process QSR Compliance HIPAA for Medical Devices Device Cybersecurity Resources
FDA Pathway Selection
Determine the appropriate FDA regulatory pathway based on device classification and predicate availability.
Decision Framework
Predicate device exists? ├── YES → Substantially equivalent? │ ├── YES → 510(k) Pathway │ │ ├── No design changes → Abbreviated 510(k) │ │ ├── Manufacturing only → Special 510(k) │ │ └── Design/performance → Traditional 510(k) │ └── NO → PMA or De Novo └── NO → Novel device? ├── Low-to-moderate risk → De Novo └── High risk (Class III) → PMA
Pathway Comparison
| Pathway | When to Use | Timeline | Cost |
|---|---|---|---|
| 510(k) Traditional | Predicate exists, design changes | 90 days | $21,760 |
| 510(k) Special | Manufacturing changes only | 30 days | $21,760 |
| 510(k) Abbreviated | Guidance/standard conformance | 30 days | $21,760 |
| De Novo | Novel, low-moderate risk | 150 days | $134,676 |
| PMA | Class III, no predicate | 180+ days | $425,000+ |
Pre-Submission Strategy
Identify product code and classification Assess substantial equivalence feasibility Prepare Q-Sub questions for FDA Schedule Pre-Sub meeting if needed
Reference: See fda_submission_guide.md for pathway decision matrices and submission requirements.
510(k) Submission Process
Workflow
Phase 1: Planning ├── Step 1: Identify predicate device(s) ├── Step 2: Compare intended use and technology ├── Step 3: Determine testing requirements └── Checkpoint: SE argument feasible?
Phase 2: Preparation ├── Step 4: Complete performance testing ├── Step 5: Prepare device description ├── Step 6: Document SE comparison ├── Step 7: Finalize labeling └── Checkpoint: All required sections complete?
Phase 3: Submission ├── Step 8: Assemble submission package ├── Step 9: Submit via eSTAR ├── Step 10: Track acknowledgment └── Checkpoint: Submission accepted?
Phase 4: Review ├── Step 11: Monitor review status ├── Step 12: Respond to AI requests ├── Step 13: Receive decision └── Verification: SE letter received?
Required Sections (21 CFR 807.87)
| Section | Content |
|---|---|
| Cover Letter | Submission type, device ID, contact info |
| Form 3514 | CDRH premarket review cover sheet |
| Device Description | Physical description, principles of operation |
| Indications for Use | Form 3881, patient population, use environment |
| SE Comparison | Side-by-side comparison with predicate |
| Performance Testing | Bench, biocompatibility, electrical safety |
| Software Documentation | Level of concern, hazard analysis (IEC 62304) |
| Labeling | IFU, package labels, warnings |
| 510(k) Summary | Public summary of submission |
Common RTA Issues
| Issue | Prevention |
|---|---|
| Missing user fee | Verify payment before submission |
| Incomplete Form 3514 | Review all fields, ensure signature |
| No predicate identified | Confirm K-number in FDA database |
| Inadequate SE comparison | Address all technological characteristics |
QSR Compliance
Quality System Regulation (21 CFR Part 820) requirements for medical device manufacturers.
Key Subsystems
| Section | Title | Focus |
|---|---|---|
| 820.20 | Management Responsibility | Quality policy, org structure, management review |
| 820.30 | Design Controls | Input, output, review, verification, validation |
| 820.40 | Document Controls | Approval, distribution, change control |
| 820.50 | Purchasing Controls | Supplier qualification, purchasing data |
| 820.70 | Production Controls | Process validation, environmental controls |
| 820.100 | CAPA | Root cause analysis, corrective actions |
| 820.181 | Device Master Record | Specifications, procedures, acceptance criteria |
Design Controls Workflow (820.30)
Step 1: Design Input └── Capture user needs, intended use, regulatory requirements Verification: Inputs reviewed and approved?
Step 2: Design Output └── Create specifications, drawings, software architecture Verification: Outputs traceable to inputs?
Step 3: Design Review └── Conduct reviews at each phase milestone Verification: Review records with signatures?
Step 4: Design Verification └── Perform testing against specifications Verification: All tests pass acceptance criteria?
Step 5: Design Validation └── Confirm device meets user needs in actual use conditions Verification: Validation report approved?
Step 6: Design Transfer └── Release to production with DMR complete Verification: Transfer checklist complete?
CAPA Process (820.100)
Identify: Document nonconformity or potential problem Investigate: Perform root cause analysis (5 Whys, Fishbone) Plan: Define corrective/preventive actions Implement: Execute actions, update documentation Verify: Confirm implementation complete Effectiveness: Monitor for recurrence (30-90 days) Close: Management approval and closure
Reference: See qsr_compliance_requirements.md for detailed QSR implementation guidance.
HIPAA for Medical Devices
HIPAA requirements for devices that create, store, transmit, or access Protected Health Information (PHI).
Applicability
| Device Type | HIPAA Applies |
|---|---|
| Standalone diagnostic (no data transmission) | No |
| Connected device transmitting patient data | Yes |
| Device with EHR integration | Yes |
| SaMD storing patient information | Yes |
| Wellness app (no diagnosis) | Only if stores PHI |
Required Safeguards
Administrative (§164.308) ├── Security officer designation ├── Risk analysis and management ├── Workforce training ├── Incident response procedures └── Business associate agreements
Physical (§164.310) ├── Facility access controls ├── Workstation security └── Device disposal procedures
Technical (§164.312) ├── Access control (unique IDs, auto-logoff) ├── Audit controls (logging) ├── Integrity controls (checksums, hashes) ├── Authentication (MFA recommended) └── Transmission security (TLS 1.2+)
Risk Assessment Steps
Inventory all systems handling ePHI Document data flows (collection, storage, transmission) Identify threats and vulnerabilities Assess likelihood and impact Determine risk levels Implement controls Document residual risk
Reference: See hipaa_compliance_framework.md for implementation checklists and BAA templates.
Device Cybersecurity
FDA cybersecurity requirements for connected medical devices.
Premarket Requirements
| Element | Description |
|---|---|
| Threat Model | STRIDE analysis, attack trees, trust boundaries |
| Security Controls | Authentication, encryption, access control |
| SBOM | Software Bill of Materials (CycloneDX or SPDX) |
| Security Testing | Penetration testing, vulnerability scanning |
| Vulnerability Plan | Disclosure process, patch management |